Valentí Gómez

878 total citations
17 papers, 627 citations indexed

About

Valentí Gómez is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Valentí Gómez has authored 17 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cell Biology and 5 papers in Cancer Research. Recurrent topics in Valentí Gómez's work include Cancer, Hypoxia, and Metabolism (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and DNA Repair Mechanisms (2 papers). Valentí Gómez is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and DNA Repair Mechanisms (2 papers). Valentí Gómez collaborates with scholars based in United Kingdom, Spain and France. Valentí Gómez's co-authors include Alexander Hergovich, Marta Gómez-Ferrer, Lily Hoa, Anna Santamaría, Timothy M. Thomson, Rosanna Paciucci, Elisabeth Castellanos, Ramazan Gündoğdu, Rami Mustapha and Tony Ng and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Valentí Gómez

16 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valentí Gómez United Kingdom 13 402 242 118 95 72 17 627
Caroline Reynaud France 12 480 1.2× 190 0.8× 153 1.3× 141 1.5× 70 1.0× 21 670
Youngdong Yoo United States 10 512 1.3× 297 1.2× 76 0.6× 90 0.9× 50 0.7× 10 719
Reniqua House United States 11 391 1.0× 78 0.3× 157 1.3× 50 0.5× 74 1.0× 11 520
Arindam Chaudhury United States 6 659 1.6× 104 0.4× 184 1.6× 197 2.1× 67 0.9× 6 847
Shunsuke Kon Japan 15 314 0.8× 252 1.0× 76 0.6× 135 1.4× 166 2.3× 29 662
Mihir Rajurkar United States 9 518 1.3× 274 1.1× 63 0.5× 135 1.4× 59 0.8× 12 708
Sarah E. Woodfield United States 17 388 1.0× 134 0.6× 128 1.1× 106 1.1× 57 0.8× 30 564
Kwok Peng Ng United States 14 552 1.4× 91 0.4× 79 0.7× 112 1.2× 106 1.5× 20 741
Bercin Kutluk Cenik United States 10 365 0.9× 92 0.4× 71 0.6× 94 1.0× 27 0.4× 12 495
Xu Peng United States 10 451 1.1× 219 0.9× 107 0.9× 65 0.7× 37 0.5× 19 697

Countries citing papers authored by Valentí Gómez

Since Specialization
Citations

This map shows the geographic impact of Valentí Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentí Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentí Gómez more than expected).

Fields of papers citing papers by Valentí Gómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentí Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentí Gómez. The network helps show where Valentí Gómez may publish in the future.

Co-authorship network of co-authors of Valentí Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of Valentí Gómez. A scholar is included among the top collaborators of Valentí Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentí Gómez. Valentí Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Martin, Bénédicte, Elizabeth Horsley, Laurie Baxter, et al.. (2025). Abstract 6736: Preclinical development of ADCT-241, a novel exatecan-based antibody-drug conjugate targeting PSMA for the treatment of prostate cancer. Cancer Research. 85(8_Supplement_1). 6736–6736.
2.
Tan, Choon Ping, Bríd M. Ryan, Valentí Gómez, et al.. (2022). Abstract 382: MTL-STING restores endogenous STING expression for improving efficacy of cancer therapeutics. Cancer Research. 82(12_Supplement). 382–382. 2 indexed citations
3.
Gündoğdu, Ramazan, Victoria J. Spanswick, Juan José García-Gómez, et al.. (2021). hMOB2 deficiency impairs homologous recombination-mediated DNA repair and sensitises cancer cells to PARP inhibitors. Cellular Signalling. 87. 110106–110106. 8 indexed citations
4.
Tan, Choon Ping, Laura Sinigaglia, Valentí Gómez, Joanna P. Nicholls, & Nagy Habib. (2021). RNA Activation—A Novel Approach to Therapeutically Upregulate Gene Transcription. Molecules. 26(21). 6530–6530. 32 indexed citations
5.
Gómez, Valentí, Thomas R. Eykyn, Rami Mustapha, et al.. (2020). Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells. Science Signaling. 13(652). 58 indexed citations
6.
Gómez, Valentí, Rami Mustapha, Kenrick Ng, & Tony Ng. (2020). Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches. British Journal of Clinical Pharmacology. 86(9). 1726–1735. 22 indexed citations
7.
Gómez, Valentí, Inés de Torres, Juan Moróte, et al.. (2019). A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells. Cancer Letters. 452. 158–167. 4 indexed citations
8.
Hoa, Lily, et al.. (2016). The characterisation of LATS2 kinase regulation in Hippo-YAP signalling. Cellular Signalling. 28(5). 488–497. 55 indexed citations
9.
Joffre, Carine, Nicolas Dupont, Lily Hoa, et al.. (2015). The Pro-apoptotic STK38 Kinase Is a New Beclin1 Partner Positively Regulating Autophagy. Current Biology. 25(19). 2479–2492. 46 indexed citations
10.
Hoa, Lily, et al.. (2014). Constitutively active NDR1-PIF kinase functions independent of MST1 and hMOB1 signalling. Cellular Signalling. 26(8). 1657–1667. 27 indexed citations
11.
Gómez, Valentí, Ramazan Gündoğdu, Marta Gómez-Ferrer, et al.. (2014). Regulation of DNA damage responses and cell cycle progression by hMOB2. Cellular Signalling. 27(2). 326–339. 28 indexed citations
12.
Fernández‐Barral, Asunción, José L. Orgaz, Pablo Baquero, et al.. (2014). Regulatory and Functional Connection of Microphthalmia-Associated Transcription Factor and Anti-Metastatic Pigment Epithelium Derived Factor in Melanoma. Neoplasia. 16(6). 529–542. 23 indexed citations
13.
Gómez-Ferrer, Marta, Valentí Gómez, & Alexander Hergovich. (2014). The Hippo pathway in disease and therapy: cancer and beyond. Clinical and Translational Medicine. 3(1). 54 indexed citations
14.
Guilhamon, Paul, Malihe Eskandarpour, Dina Halai, et al.. (2013). Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2. Nature Communications. 4(1). 2166–2166. 130 indexed citations
15.
Fernández‐Barral, Asunción, José L. Orgaz, Valentí Gómez, et al.. (2012). Hypoxia Negatively Regulates Antimetastatic PEDF in Melanoma Cells by a Hypoxia Inducible Factor-Independent, Autophagy Dependent Mechanism. PLoS ONE. 7(3). e32989–e32989. 25 indexed citations
16.
Gómez, Valentí, Marta Sesé, Anna Santamaría, et al.. (2010). Regulation of Aurora B Kinase by the Lipid Raft Protein Flotillin-1. Journal of Biological Chemistry. 285(27). 20683–20690. 25 indexed citations
17.
Santamaría, Anna, Elisabeth Castellanos, Valentí Gómez, et al.. (2005). PTOV1 Enables the Nuclear Translocation and Mitogenic Activity of Flotillin-1, a Major Protein of Lipid Rafts. Molecular and Cellular Biology. 25(5). 1900–1911. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026